Hemoglobin catabolism following a hemolytic transfusion reaction in a patient with sickle cell anemia.
D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood*; D001663:Bilirubin / Q000097:blood; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000209:etiology; D001787:Blood Group Incompatibility; D001792:Blood Platelets; D005260:Female; D005337:Fibrin / Q000032:analysis; D006073:Gout / Q000188:drug therapy / Q000209:etiology; D006386:Hemagglutination Tests; D006454:Hemoglobins / Q000378:metabolism; D006456:Hemoglobinuria / Q000175:diagnosis; D006461:Hemolysis; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D007122:Immunoelectrophoresis; D007213:Indomethacin / Q000627:therapeutic use; D007518:Isoantibodies; D007962:Leukocytes / Q000276:immunology; D008353:Mannitol / Q000627:therapeutic use; D065227:Transfusion Reaction; D014527:Uric Acid / Q000097:blood
D006454:Hemoglobins; D007518:Isoantibodies; D014527:Uric Acid; D008353:Mannitol; D005337:Fibrin; D001663:Bilirubin; D007213:Indomethacin